Designed around the way
your specialty works.
Order → accession → specimen/aliquot → assay run → verified result and amendments.
Order catalogue specifies specimen, container, preparation, collection timing, urgency and performing laboratory.
Phlebotomy and reception capture barcode, collector, transport conditions, acceptance/rejection and aliquot genealogy.
Benches manage worklists, analyser runs, calibration, internal QC, reagent lots, reflex testing and repeats with explicit reasons.
Authorized staff validate results, communicate critical findings, issue corrected reports and support microbiology organism/antimicrobial susceptibility structures.
Diagnosis coverage and clinical records
Laboratories principally report tests and interpretations: haematology, chemistry, endocrinology, immunology, serology, microbiology and molecular diagnostics. Keep clinician diagnosis/indication separate from detected organism, abnormal analyte or laboratory interpretive comment.
Measurements that give the record meaning
| Measurement | Units / representation | Clinical context |
|---|---|---|
| Haematology | g/L or g/dL; ×10⁹/L; fL | Analyte, specimen, method and population interval |
| Chemistry/electrolytes | mmol/L; mg/dL; µmol/L | Analyte-specific units, haemolysis and dilution |
| Coagulation | seconds; ratio; INR | Method, anticoagulant context and specimen |
| Culture/organism | coded presence; quantity | Specimen site, isolate identifier and collection |
| Antimicrobial susceptibility | mg/L; category | MIC or zone in mm, method and breakpoint edition |
| Molecular result | qualitative; copies/mL; Ct if appropriate | Assay, target, detection limit and interpretation |
| QC metrics | control value; SD; CV% | Control lot, level, run and rejection rule |
Equipment and integration plans
- Chemistry, haematology, coagulation, immunoassay, blood gas, microbiology and PCR instruments → LIS/middleware, usually model-specific HL7 v2, ASTM-derived or vendor protocols.
- Orders may travel out and results return only where both directions are supported; portable POCT also needs operator competency and device QC information.
Connections require an approved interface and testing against the installed manufacturer, model and software. Listed equipment is a candidate integration target.
Explore equipment & roboticsReporting and meaningful outcomes
Turnaround by collection/receipt/verification separately; specimen rejection per received specimen; critical-result acknowledgement; QC failures by run.
Development scope and clinical validation
Initial scope
Accessioning, specimen tracking, manual result validation, critical notification and quality logs.
Advanced scope
Validated analyser interfaces, constrained auto-verification and microbiology surveillance.
Example acceptance scenarios
- Failed QC must prevent routine auto-release for affected tests; replayed results must not duplicate observations.
- A corrected result must retain the previous value and reach the prior report recipients; unit mapping errors must quarantine the result.
Research foundations
Research snapshot: 23 September 2026. References inform the proposed design; they do not certify FertPro or establish device compatibility. Diagnosis lists and measurement groups are not treatment protocols.